Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Dec;37(12):905–915. doi: 10.1136/jmg.37.12.905

Chromatin modification and disease

C Johnson 1
PMCID: PMC1734499  PMID: 11106353

Full Text

The Full Text of this article is available as a PDF (192.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarnisalo P., Palvimo J. J., Jänne O. A. CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2122–2127. doi: 10.1073/pnas.95.5.2122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aasland R., Gibson T. J., Stewart A. F. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci. 1995 Feb;20(2):56–59. doi: 10.1016/s0968-0004(00)88957-4. [DOI] [PubMed] [Google Scholar]
  3. Airio A., Pukkala E., Isomäki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol. 1995 Jul;22(7):1300–1303. [PubMed] [Google Scholar]
  4. Alland L., Muhle R., Hou H., Jr, Potes J., Chin L., Schreiber-Agus N., DePinho R. A. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature. 1997 May 1;387(6628):49–55. doi: 10.1038/387049a0. [DOI] [PubMed] [Google Scholar]
  5. Amir R. E., Van den Veyver I. B., Wan M., Tran C. Q., Francke U., Zoghbi H. Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999 Oct;23(2):185–188. doi: 10.1038/13810. [DOI] [PubMed] [Google Scholar]
  6. Archer S. Y., Hodin R. A. Histone acetylation and cancer. Curr Opin Genet Dev. 1999 Apr;9(2):171–174. doi: 10.1016/s0959-437x(99)80026-4. [DOI] [PubMed] [Google Scholar]
  7. Archer S. Y., Meng S., Shei A., Hodin R. A. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6791–6796. doi: 10.1073/pnas.95.12.6791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ayer D. E., Lawrence Q. A., Eisenman R. N. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell. 1995 Mar 10;80(5):767–776. doi: 10.1016/0092-8674(95)90355-0. [DOI] [PubMed] [Google Scholar]
  9. Bader S., Walker M., Hendrich B., Bird A., Bird C., Hooper M., Wyllie A. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene. 1999 Dec 23;18(56):8044–8047. doi: 10.1038/sj.onc.1203229. [DOI] [PubMed] [Google Scholar]
  10. Bannister A. J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 1996 Dec 19;384(6610):641–643. doi: 10.1038/384641a0. [DOI] [PubMed] [Google Scholar]
  11. Bestor T. H., Verdine G. L. DNA methyltransferases. Curr Opin Cell Biol. 1994 Jun;6(3):380–389. doi: 10.1016/0955-0674(94)90030-2. [DOI] [PubMed] [Google Scholar]
  12. Bird A. P., Wolffe A. P. Methylation-induced repression--belts, braces, and chromatin. Cell. 1999 Nov 24;99(5):451–454. doi: 10.1016/s0092-8674(00)81532-9. [DOI] [PubMed] [Google Scholar]
  13. Bird A. The essentials of DNA methylation. Cell. 1992 Jul 10;70(1):5–8. doi: 10.1016/0092-8674(92)90526-i. [DOI] [PubMed] [Google Scholar]
  14. Blanco J. C., Minucci S., Lu J., Yang X. J., Walker K. K., Chen H., Evans R. M., Nakatani Y., Ozato K. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 1998 Jun 1;12(11):1638–1651. doi: 10.1101/gad.12.11.1638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5889–5892. doi: 10.1073/pnas.90.13.5889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Borrow J., Stanton V. P., Jr, Andresen J. M., Becher R., Behm F. G., Chaganti R. S., Civin C. I., Disteche C., Dubé I., Frischauf A. M. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet. 1996 Sep;14(1):33–41. doi: 10.1038/ng0996-33. [DOI] [PubMed] [Google Scholar]
  17. Boyes J., Byfield P., Nakatani Y., Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 1998 Dec 10;396(6711):594–598. doi: 10.1038/25166. [DOI] [PubMed] [Google Scholar]
  18. Bradbury E. M. Reversible histone modifications and the chromosome cell cycle. Bioessays. 1992 Jan;14(1):9–16. doi: 10.1002/bies.950140103. [DOI] [PubMed] [Google Scholar]
  19. Brehm A., Kouzarides T. Retinoblastoma protein meets chromatin. Trends Biochem Sci. 1999 Apr;24(4):142–145. doi: 10.1016/s0968-0004(99)01368-7. [DOI] [PubMed] [Google Scholar]
  20. Brehm A., Miska E. A., McCance D. J., Reid J. L., Bannister A. J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature. 1998 Feb 5;391(6667):597–601. doi: 10.1038/35404. [DOI] [PubMed] [Google Scholar]
  21. Brosch G., Ransom R., Lechner T., Walton J. D., Loidl P. Inhibition of maize histone deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum. Plant Cell. 1995 Nov;7(11):1941–1950. doi: 10.1105/tpc.7.11.1941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Brugarolas J., Chandrasekaran C., Gordon J. I., Beach D., Jacks T., Hannon G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 1995 Oct 12;377(6549):552–557. doi: 10.1038/377552a0. [DOI] [PubMed] [Google Scholar]
  23. Candido E. P., Reeves R., Davie J. R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell. 1978 May;14(1):105–113. doi: 10.1016/0092-8674(78)90305-7. [DOI] [PubMed] [Google Scholar]
  24. Carapeti M., Aguiar R. C., Goldman J. M., Cross N. C. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood. 1998 May 1;91(9):3127–3133. [PubMed] [Google Scholar]
  25. Casini T., Pelicci P. G. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Oncogene. 1999 May 27;18(21):3235–3243. doi: 10.1038/sj.onc.1202630. [DOI] [PubMed] [Google Scholar]
  26. Chakravarti D., LaMorte V. J., Nelson M. C., Nakajima T., Schulman I. G., Juguilon H., Montminy M., Evans R. M. Role of CBP/P300 in nuclear receptor signalling. Nature. 1996 Sep 5;383(6595):99–103. doi: 10.1038/383099a0. [DOI] [PubMed] [Google Scholar]
  27. Chen D., Ma H., Hong H., Koh S. S., Huang S. M., Schurter B. T., Aswad D. W., Stallcup M. R. Regulation of transcription by a protein methyltransferase. Science. 1999 Jun 25;284(5423):2174–2177. doi: 10.1126/science.284.5423.2174. [DOI] [PubMed] [Google Scholar]
  28. Chen H., Lin R. J., Schiltz R. L., Chakravarti D., Nash A., Nagy L., Privalsky M. L., Nakatani Y., Evans R. M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 1997 Aug 8;90(3):569–580. doi: 10.1016/s0092-8674(00)80516-4. [DOI] [PubMed] [Google Scholar]
  29. Chen H., Lin R. J., Xie W., Wilpitz D., Evans R. M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 1999 Sep 3;98(5):675–686. doi: 10.1016/s0092-8674(00)80054-9. [DOI] [PubMed] [Google Scholar]
  30. Chudley A. E., Lowry R. B. X linked alpha thalassaemia/mental retardation (ATR-X) syndrome. J Med Genet. 1992 May;29(5):357–357. doi: 10.1136/jmg.29.5.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Deltour S., Guerardel C., Leprince D. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14831–14836. doi: 10.1073/pnas.96.26.14831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dhalluin C., Carlson J. E., Zeng L., He C., Aggarwal A. K., Zhou M. M. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 1999 Jun 3;399(6735):491–496. doi: 10.1038/20974. [DOI] [PubMed] [Google Scholar]
  33. Dhordain P., Albagli O., Lin R. J., Ansieau S., Quief S., Leutz A., Kerckaert J. P., Evans R. M., Leprince D. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10762–10767. doi: 10.1073/pnas.94.20.10762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Dunaief J. L., Strober B. E., Guha S., Khavari P. A., Alin K., Luban J., Begemann M., Crabtree G. R., Goff S. P. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 1994 Oct 7;79(1):119–130. doi: 10.1016/0092-8674(94)90405-7. [DOI] [PubMed] [Google Scholar]
  35. Faust C., Schumacher A., Holdener B., Magnuson T. The eed mutation disrupts anterior mesoderm production in mice. Development. 1995 Feb;121(2):273–285. doi: 10.1242/dev.121.2.273. [DOI] [PubMed] [Google Scholar]
  36. Ferreira R., Magnaghi-Jaulin L., Robin P., Harel-Bellan A., Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10493–10498. doi: 10.1073/pnas.95.18.10493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Finnin M. S., Donigian J. R., Cohen A., Richon V. M., Rifkind R. A., Marks P. A., Breslow R., Pavletich N. P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature. 1999 Sep 9;401(6749):188–193. doi: 10.1038/43710. [DOI] [PubMed] [Google Scholar]
  38. Fuks F., Burgers W. A., Brehm A., Hughes-Davies L., Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet. 2000 Jan;24(1):88–91. doi: 10.1038/71750. [DOI] [PubMed] [Google Scholar]
  39. Gibbons R. J., Bachoo S., Picketts D. J., Aftimos S., Asenbauer B., Bergoffen J., Berry S. A., Dahl N., Fryer A., Keppler K. Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet. 1997 Oct;17(2):146–148. doi: 10.1038/ng1097-146. [DOI] [PubMed] [Google Scholar]
  40. Gibbons R. J., McDowell T. L., Raman S., O'Rourke D. M., Garrick D., Ayyub H., Higgs D. R. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet. 2000 Apr;24(4):368–371. doi: 10.1038/74191. [DOI] [PubMed] [Google Scholar]
  41. Gibbons R. J., Picketts D. J., Villard L., Higgs D. R. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 1995 Mar 24;80(6):837–845. doi: 10.1016/0092-8674(95)90287-2. [DOI] [PubMed] [Google Scholar]
  42. Grand F., Kulkarni S., Chase A., Goldman J. M., Gordon M., Cross N. C. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res. 1999 Aug 15;59(16):3870–3874. [PubMed] [Google Scholar]
  43. Grant P. A., Berger S. L. Histone acetyltransferase complexes. Semin Cell Dev Biol. 1999 Apr;10(2):169–177. doi: 10.1006/scdb.1999.0298. [DOI] [PubMed] [Google Scholar]
  44. Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F. F., Zamir I. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature. 1998 Feb 19;391(6669):815–818. doi: 10.1038/35901. [DOI] [PubMed] [Google Scholar]
  45. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F., Pelicci P. G. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994 Jan 1;83(1):10–25. [PubMed] [Google Scholar]
  46. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997 Sep 25;389(6649):349–352. doi: 10.1038/38664. [DOI] [PubMed] [Google Scholar]
  47. Gu W., Roeder R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997 Aug 22;90(4):595–606. doi: 10.1016/s0092-8674(00)80521-8. [DOI] [PubMed] [Google Scholar]
  48. Guarente L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 2000 May 1;14(9):1021–1026. [PubMed] [Google Scholar]
  49. Hagberg B., Aicardi J., Dias K., Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol. 1983 Oct;14(4):471–479. doi: 10.1002/ana.410140412. [DOI] [PubMed] [Google Scholar]
  50. Hassig C. A., Tong J. K., Fleischer T. C., Owa T., Grable P. G., Ayer D. E., Schreiber S. L. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3519–3524. doi: 10.1073/pnas.95.7.3519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Heinzel T., Lavinsky R. M., Mullen T. M., Söderstrom M., Laherty C. D., Torchia J., Yang W. M., Brard G., Ngo S. D., Davie J. R. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature. 1997 May 1;387(6628):43–48. doi: 10.1038/387043a0. [DOI] [PubMed] [Google Scholar]
  52. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol. 1998 Nov;18(11):6538–6547. doi: 10.1128/mcb.18.11.6538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Hendrich B., Hardeland U., Ng H. H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 1999 Sep 16;401(6750):301–304. doi: 10.1038/45843. [DOI] [PubMed] [Google Scholar]
  54. Henriksson M., Lüscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res. 1996;68:109–182. doi: 10.1016/s0065-230x(08)60353-x. [DOI] [PubMed] [Google Scholar]
  55. Herman J. G., Umar A., Polyak K., Graff J. R., Ahuja N., Issa J. P., Markowitz S., Willson J. K., Hamilton S. R., Kinzler K. W. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870–6875. doi: 10.1073/pnas.95.12.6870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hinds P. W., Mittnacht S., Dulic V., Arnold A., Reed S. I., Weinberg R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 1992 Sep 18;70(6):993–1006. doi: 10.1016/0092-8674(92)90249-c. [DOI] [PubMed] [Google Scholar]
  57. Hong S. H., David G., Wong C. W., Dejean A., Privalsky M. L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9028–9033. doi: 10.1073/pnas.94.17.9028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Hoshikawa Y., Kwon H. J., Yoshida M., Horinouchi S., Beppu T. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res. 1994 Sep;214(1):189–197. doi: 10.1006/excr.1994.1248. [DOI] [PubMed] [Google Scholar]
  59. Imai S., Armstrong C. M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000 Feb 17;403(6771):795–800. doi: 10.1038/35001622. [DOI] [PubMed] [Google Scholar]
  60. Imhof A., Yang X. J., Ogryzko V. V., Nakatani Y., Wolffe A. P., Ge H. Acetylation of general transcription factors by histone acetyltransferases. Curr Biol. 1997 Sep 1;7(9):689–692. doi: 10.1016/s0960-9822(06)00296-x. [DOI] [PubMed] [Google Scholar]
  61. Itazaki H., Nagashima K., Sugita K., Yoshida H., Kawamura Y., Yasuda Y., Matsumoto K., Ishii K., Uotani N., Nakai H. Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents. J Antibiot (Tokyo) 1990 Dec;43(12):1524–1532. doi: 10.7164/antibiotics.43.1524. [DOI] [PubMed] [Google Scholar]
  62. Janknecht R., Hunter T. Versatile molecular glue. Transcriptional control. Curr Biol. 1996 Aug 1;6(8):951–954. doi: 10.1016/s0960-9822(02)00636-x. [DOI] [PubMed] [Google Scholar]
  63. Johnson C. A., Turner B. M. Histone deacetylases: complex transducers of nuclear signals. Semin Cell Dev Biol. 1999 Apr;10(2):179–188. doi: 10.1006/scdb.1999.0299. [DOI] [PubMed] [Google Scholar]
  64. Jones P. A., Laird P. W. Cancer epigenetics comes of age. Nat Genet. 1999 Feb;21(2):163–167. doi: 10.1038/5947. [DOI] [PubMed] [Google Scholar]
  65. Kaelin W. G., Jr, Ewen M. E., Livingston D. M. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol. 1990 Jul;10(7):3761–3769. doi: 10.1128/mcb.10.7.3761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S. C., Heyman R. A., Rose D. W., Glass C. K. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 1996 May 3;85(3):403–414. doi: 10.1016/s0092-8674(00)81118-6. [DOI] [PubMed] [Google Scholar]
  67. Kijima M., Yoshida M., Sugita K., Horinouchi S., Beppu T. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem. 1993 Oct 25;268(30):22429–22435. [PubMed] [Google Scholar]
  68. Kim J., Sif S., Jones B., Jackson A., Koipally J., Heller E., Winandy S., Viel A., Sawyer A., Ikeda T. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity. 1999 Mar;10(3):345–355. doi: 10.1016/s1074-7613(00)80034-5. [DOI] [PubMed] [Google Scholar]
  69. Kingston R. E., Bunker C. A., Imbalzano A. N. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev. 1996 Apr 15;10(8):905–920. doi: 10.1101/gad.10.8.905. [DOI] [PubMed] [Google Scholar]
  70. Koipally J., Renold A., Kim J., Georgopoulos K. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 1999 Jun 1;18(11):3090–3100. doi: 10.1093/emboj/18.11.3090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Kornberg R. D., Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell. 1999 Aug 6;98(3):285–294. doi: 10.1016/s0092-8674(00)81958-3. [DOI] [PubMed] [Google Scholar]
  72. Korzus E., Torchia J., Rose D. W., Xu L., Kurokawa R., McInerney E. M., Mullen T. M., Glass C. K., Rosenfeld M. G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 1998 Jan 30;279(5351):703–707. doi: 10.1126/science.279.5351.703. [DOI] [PubMed] [Google Scholar]
  73. Kraus W. L., Kadonaga J. T. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 1998 Feb 1;12(3):331–342. doi: 10.1101/gad.12.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Kuo M. H., Zhou J., Jambeck P., Churchill M. E., Allis C. D. Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes Dev. 1998 Mar 1;12(5):627–639. doi: 10.1101/gad.12.5.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Kwon H. J., Owa T., Hassig C. A., Shimada J., Schreiber S. L. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3356–3361. doi: 10.1073/pnas.95.7.3356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Laird P. W., Jackson-Grusby L., Fazeli A., Dickinson S. L., Jung W. E., Li E., Weinberg R. A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 1995 Apr 21;81(2):197–205. doi: 10.1016/0092-8674(95)90329-1. [DOI] [PubMed] [Google Scholar]
  77. Landry J., Sutton A., Tafrov S. T., Heller R. C., Stebbins J., Pillus L., Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A. 2000 May 23;97(11):5807–5811. doi: 10.1073/pnas.110148297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Li J. Y., English M. A., Ball H. J., Yeyati P. L., Waxman S., Licht J. D. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J Biol Chem. 1997 Sep 5;272(36):22447–22455. doi: 10.1074/jbc.272.36.22447. [DOI] [PubMed] [Google Scholar]
  79. Licht J. D., Chomienne C., Goy A., Chen A., Scott A. A., Head D. R., Michaux J. L., Wu Y., DeBlasio A., Miller W. H., Jr Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood. 1995 Feb 15;85(4):1083–1094. [PubMed] [Google Scholar]
  80. Lin R. J., Nagy L., Inoue S., Shao W., Miller W. H., Jr, Evans R. M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 1998 Feb 19;391(6669):811–814. doi: 10.1038/35895. [DOI] [PubMed] [Google Scholar]
  81. Liu L., Scolnick D. M., Trievel R. C., Zhang H. B., Marmorstein R., Halazonetis T. D., Berger S. L. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol. 1999 Feb;19(2):1202–1209. doi: 10.1128/mcb.19.2.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Luger K., Mäder A. W., Richmond R. K., Sargent D. F., Richmond T. J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997 Sep 18;389(6648):251–260. doi: 10.1038/38444. [DOI] [PubMed] [Google Scholar]
  83. Luger K., Richmond T. J. The histone tails of the nucleosome. Curr Opin Genet Dev. 1998 Apr;8(2):140–146. doi: 10.1016/s0959-437x(98)80134-2. [DOI] [PubMed] [Google Scholar]
  84. Luo R. X., Postigo A. A., Dean D. C. Rb interacts with histone deacetylase to repress transcription. Cell. 1998 Feb 20;92(4):463–473. doi: 10.1016/s0092-8674(00)80940-x. [DOI] [PubMed] [Google Scholar]
  85. Ma Q., Alder H., Nelson K. K., Chatterjee D., Gu Y., Nakamura T., Canaani E., Croce C. M., Siracusa L. D., Buchberg A. M. Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6350–6354. doi: 10.1073/pnas.90.13.6350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J. P., Troalen F., Trouche D., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 1998 Feb 5;391(6667):601–605. doi: 10.1038/35410. [DOI] [PubMed] [Google Scholar]
  87. Martínez-Balbás M. A., Bauer U. M., Nielsen S. J., Brehm A., Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 2000 Feb 15;19(4):662–671. doi: 10.1093/emboj/19.4.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Mizzen C. A., Yang X. J., Kokubo T., Brownell J. E., Bannister A. J., Owen-Hughes T., Workman J., Wang L., Berger S. L., Kouzarides T. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell. 1996 Dec 27;87(7):1261–1270. doi: 10.1016/s0092-8674(00)81821-8. [DOI] [PubMed] [Google Scholar]
  89. Muchardt C., Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 1993 Nov;12(11):4279–4290. doi: 10.1002/j.1460-2075.1993.tb06112.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Muchardt C., Yaniv M. The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol. 1999 Apr;10(2):189–195. doi: 10.1006/scdb.1999.0300. [DOI] [PubMed] [Google Scholar]
  91. Murphy M., Ahn J., Walker K. K., Hoffman W. H., Evans R. M., Levine A. J., George D. L. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 1999 Oct 1;13(19):2490–2501. doi: 10.1101/gad.13.19.2490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Nagy L., Kao H. Y., Chakravarti D., Lin R. J., Hassig C. A., Ayer D. E., Schreiber S. L., Evans R. M. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell. 1997 May 2;89(3):373–380. doi: 10.1016/s0092-8674(00)80218-4. [DOI] [PubMed] [Google Scholar]
  93. Nakajima H., Kim Y. B., Terano H., Yoshida M., Horinouchi S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp Cell Res. 1998 May 25;241(1):126–133. doi: 10.1006/excr.1998.4027. [DOI] [PubMed] [Google Scholar]
  94. Nan X., Ng H. H., Johnson C. A., Laherty C. D., Turner B. M., Eisenman R. N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998 May 28;393(6683):386–389. doi: 10.1038/30764. [DOI] [PubMed] [Google Scholar]
  95. Ng H. H., Bird A. Histone deacetylases: silencers for hire. Trends Biochem Sci. 2000 Mar;25(3):121–126. doi: 10.1016/s0968-0004(00)01551-6. [DOI] [PubMed] [Google Scholar]
  96. Ng H. H., Zhang Y., Hendrich B., Johnson C. A., Turner B. M., Erdjument-Bromage H., Tempst P., Reinberg D., Bird A. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet. 1999 Sep;23(1):58–61. doi: 10.1038/12659. [DOI] [PubMed] [Google Scholar]
  97. Ogryzko V. V., Schiltz R. L., Russanova V., Howard B. H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996 Nov 29;87(5):953–959. doi: 10.1016/s0092-8674(00)82001-2. [DOI] [PubMed] [Google Scholar]
  98. Okano M., Bell D. W., Haber D. A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999 Oct 29;99(3):247–257. doi: 10.1016/s0092-8674(00)81656-6. [DOI] [PubMed] [Google Scholar]
  99. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet. 1998 Jul;19(3):219–220. doi: 10.1038/890. [DOI] [PubMed] [Google Scholar]
  100. Paranjape S. M., Kamakaka R. T., Kadonaga J. T. Role of chromatin structure in the regulation of transcription by RNA polymerase II. Annu Rev Biochem. 1994;63:265–297. doi: 10.1146/annurev.bi.63.070194.001405. [DOI] [PubMed] [Google Scholar]
  101. Petrij F., Giles R. H., Dauwerse H. G., Saris J. J., Hennekam R. C., Masuno M., Tommerup N., van Ommen G. J., Goodman R. H., Peters D. J. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995 Jul 27;376(6538):348–351. doi: 10.1038/376348a0. [DOI] [PubMed] [Google Scholar]
  102. Pirrotta V. PcG complexes and chromatin silencing. Curr Opin Genet Dev. 1997 Apr;7(2):249–258. doi: 10.1016/s0959-437x(97)80135-9. [DOI] [PubMed] [Google Scholar]
  103. Prendergast G. C., Ziff E. B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science. 1991 Jan 11;251(4990):186–189. doi: 10.1126/science.1987636. [DOI] [PubMed] [Google Scholar]
  104. Prowse A. H., Webster A. R., Richards F. M., Richard S., Olschwang S., Resche F., Affara N. A., Maher E. R. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Am J Hum Genet. 1997 Apr;60(4):765–771. [PMC free article] [PubMed] [Google Scholar]
  105. Redner R. L., Wang J., Liu J. M. Chromatin remodeling and leukemia: new therapeutic paradigms. Blood. 1999 Jul 15;94(2):417–428. [PubMed] [Google Scholar]
  106. Richon V. M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R. A., Marks P. A. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3003–3007. doi: 10.1073/pnas.95.6.3003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Roth S. Y., Allis C. D. Histone acetylation and chromatin assembly: a single escort, multiple dances? Cell. 1996 Oct 4;87(1):5–8. doi: 10.1016/s0092-8674(00)81316-1. [DOI] [PubMed] [Google Scholar]
  108. Rozenblatt-Rosen O., Rozovskaia T., Burakov D., Sedkov Y., Tillib S., Blechman J., Nakamura T., Croce C. M., Mazo A., Canaani E. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4152–4157. doi: 10.1073/pnas.95.8.4152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Sambucetti L. C., Fischer D. D., Zabludoff S., Kwon P. O., Chamberlin H., Trogani N., Xu H., Cohen D. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem. 1999 Dec 3;274(49):34940–34947. doi: 10.1074/jbc.274.49.34940. [DOI] [PubMed] [Google Scholar]
  110. Sassone-Corsi P., Mizzen C. A., Cheung P., Crosio C., Monaco L., Jacquot S., Hanauer A., Allis C. D. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science. 1999 Aug 6;285(5429):886–891. doi: 10.1126/science.285.5429.886. [DOI] [PubMed] [Google Scholar]
  111. Sealy L., Chalkley R. The effect of sodium butyrate on histone modification. Cell. 1978 May;14(1):115–121. doi: 10.1016/0092-8674(78)90306-9. [DOI] [PubMed] [Google Scholar]
  112. Seelig H. P., Moosbrugger I., Ehrfeld H., Fink T., Renz M., Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum. 1995 Oct;38(10):1389–1399. doi: 10.1002/art.1780381006. [DOI] [PubMed] [Google Scholar]
  113. Sherman J. M., Pillus L. An uncertain silence. Trends Genet. 1997 Aug;13(8):308–313. doi: 10.1016/s0168-9525(97)01198-0. [DOI] [PubMed] [Google Scholar]
  114. Shorr A. F., Yacavone M., Seguin S., Jackson L. W., Dennis G. J. Dermatomyositis and malignant melanoma. Am J Med Sci. 1997 Apr;313(4):249–251. doi: 10.1097/00000441-199704000-00011. [DOI] [PubMed] [Google Scholar]
  115. Sobulo O. M., Borrow J., Tomek R., Reshmi S., Harden A., Schlegelberger B., Housman D., Doggett N. A., Rowley J. D., Zeleznik-Le N. J. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8732–8737. doi: 10.1073/pnas.94.16.8732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Sommer A., Hilfenhaus S., Menkel A., Kremmer E., Seiser C., Loidl P., Lüscher B. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol. 1997 Jun 1;7(6):357–365. doi: 10.1016/s0960-9822(06)00183-7. [DOI] [PubMed] [Google Scholar]
  117. Spencer T. E., Jenster G., Burcin M. M., Allis C. D., Zhou J., Mizzen C. A., McKenna N. J., Onate S. A., Tsai S. Y., Tsai M. J. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 1997 Sep 11;389(6647):194–198. doi: 10.1038/38304. [DOI] [PubMed] [Google Scholar]
  118. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 1998 Mar 1;12(5):599–606. doi: 10.1101/gad.12.5.599. [DOI] [PubMed] [Google Scholar]
  119. Syntichaki P., Topalidou I., Thireos G. The Gcn5 bromodomain co-ordinates nucleosome remodelling. Nature. 2000 Mar 23;404(6776):414–417. doi: 10.1038/35006136. [DOI] [PubMed] [Google Scholar]
  120. Taunton J., Hassig C. A., Schreiber S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 1996 Apr 19;272(5260):408–411. doi: 10.1126/science.272.5260.408. [DOI] [PubMed] [Google Scholar]
  121. Thirman M. J., Gill H. J., Burnett R. C., Mbangkollo D., McCabe N. R., Kobayashi H., Ziemin-van der Poel S., Kaneko Y., Morgan R., Sandberg A. A. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med. 1993 Sep 23;329(13):909–914. doi: 10.1056/NEJM199309233291302. [DOI] [PubMed] [Google Scholar]
  122. Thomson S., Mahadevan L. C., Clayton A. L. MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Semin Cell Dev Biol. 1999 Apr;10(2):205–214. doi: 10.1006/scdb.1999.0302. [DOI] [PubMed] [Google Scholar]
  123. Toh Y., Pencil S. D., Nicolson G. L. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem. 1994 Sep 16;269(37):22958–22963. [PubMed] [Google Scholar]
  124. Trivier E., De Cesare D., Jacquot S., Pannetier S., Zackai E., Young I., Mandel J. L., Sassone-Corsi P., Hanauer A. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature. 1996 Dec 12;384(6609):567–570. doi: 10.1038/384567a0. [DOI] [PubMed] [Google Scholar]
  125. Tyler J. K., Kadonaga J. T. The "dark side" of chromatin remodeling: repressive effects on transcription. Cell. 1999 Nov 24;99(5):443–446. doi: 10.1016/s0092-8674(00)81530-5. [DOI] [PubMed] [Google Scholar]
  126. Usachenko S. I., Bavykin S. G., Gavin I. M., Bradbury E. M. Rearrangement of the histone H2A C-terminal domain in the nucleosome. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6845–6849. doi: 10.1073/pnas.91.15.6845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Varga-Weisz P. D., Becker P. B. Chromatin-remodeling factors: machines that regulate? Curr Opin Cell Biol. 1998 Jun;10(3):346–353. doi: 10.1016/s0955-0674(98)80010-0. [DOI] [PubMed] [Google Scholar]
  128. Verreault A., Kaufman P. D., Kobayashi R., Stillman B. Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase. Curr Biol. 1998 Jan 15;8(2):96–108. doi: 10.1016/s0960-9822(98)70040-5. [DOI] [PubMed] [Google Scholar]
  129. Versteege I., Sévenet N., Lange J., Rousseau-Merck M. F., Ambros P., Handgretinger R., Aurias A., Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998 Jul 9;394(6689):203–206. doi: 10.1038/28212. [DOI] [PubMed] [Google Scholar]
  130. Wade P. A., Gegonne A., Jones P. L., Ballestar E., Aubry F., Wolffe A. P. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet. 1999 Sep;23(1):62–66. doi: 10.1038/12664. [DOI] [PubMed] [Google Scholar]
  131. Walker I. O. Differential dissociation of histone tails from core chromatin. Biochemistry. 1984 Nov 6;23(23):5622–5628. doi: 10.1021/bi00318a037. [DOI] [PubMed] [Google Scholar]
  132. Wan M., Lee S. S., Zhang X., Houwink-Manville I., Song H. R., Amir R. E., Budden S., Naidu S., Pereira J. L., Lo I. F. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet. 1999 Dec;65(6):1520–1529. doi: 10.1086/302690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Wang J., Saunthararajah Y., Redner R. L., Liu J. M. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res. 1999 Jun 15;59(12):2766–2769. [PubMed] [Google Scholar]
  134. Warrell R. P., Jr, He L. Z., Richon V., Calleja E., Pandolfi P. P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst. 1998 Nov 4;90(21):1621–1625. doi: 10.1093/jnci/90.21.1621. [DOI] [PubMed] [Google Scholar]
  135. Weinberg R. A. E2F and cell proliferation: a world turned upside down. Cell. 1996 May 17;85(4):457–459. doi: 10.1016/s0092-8674(00)81244-1. [DOI] [PubMed] [Google Scholar]
  136. Winston F., Allis C. D. The bromodomain: a chromatin-targeting module? Nat Struct Biol. 1999 Jul;6(7):601–604. doi: 10.1038/10640. [DOI] [PubMed] [Google Scholar]
  137. Workman J. L., Kingston R. E. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem. 1998;67:545–579. doi: 10.1146/annurev.biochem.67.1.545. [DOI] [PubMed] [Google Scholar]
  138. Wu R. S., Panusz H. T., Hatch C. L., Bonner W. M. Histones and their modifications. CRC Crit Rev Biochem. 1986;20(2):201–263. doi: 10.3109/10409238609083735. [DOI] [PubMed] [Google Scholar]
  139. Xu G. L., Bestor T. H., Bourc'his D., Hsieh C. L., Tommerup N., Bugge M., Hulten M., Qu X., Russo J. J., Viegas-Péquignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature. 1999 Nov 11;402(6758):187–191. doi: 10.1038/46052. [DOI] [PubMed] [Google Scholar]
  140. Xu L., Glass C. K., Rosenfeld M. G. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev. 1999 Apr;9(2):140–147. doi: 10.1016/S0959-437X(99)80021-5. [DOI] [PubMed] [Google Scholar]
  141. Yang X. J., Ogryzko V. V., Nishikawa J., Howard B. H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 1996 Jul 25;382(6589):319–324. doi: 10.1038/382319a0. [DOI] [PubMed] [Google Scholar]
  142. Yoshida M., Horinouchi S., Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays. 1995 May;17(5):423–430. doi: 10.1002/bies.950170510. [DOI] [PubMed] [Google Scholar]
  143. Yoshida M., Hoshikawa Y., Koseki K., Mori K., Beppu T. Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells. J Antibiot (Tokyo) 1990 Sep;43(9):1101–1106. doi: 10.7164/antibiotics.43.1101. [DOI] [PubMed] [Google Scholar]
  144. Yoshida M., Nomura S., Beppu T. Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res. 1987 Jul 15;47(14):3688–3691. [PubMed] [Google Scholar]
  145. Yu B. D., Hess J. L., Horning S. E., Brown G. A., Korsmeyer S. J. Altered Hox expression and segmental identity in Mll-mutant mice. Nature. 1995 Nov 30;378(6556):505–508. doi: 10.1038/378505a0. [DOI] [PubMed] [Google Scholar]
  146. Zhang X. Y., Ehrlich K. C., Wang R. Y., Ehrlich M. Effect of site-specific DNA methylation and mutagenesis on recognition by methylated DNA-binding protein from human placenta. Nucleic Acids Res. 1986 Nov 11;14(21):8387–8397. doi: 10.1093/nar/14.21.8387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Zhang Y., Iratni R., Erdjument-Bromage H., Tempst P., Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell. 1997 May 2;89(3):357–364. doi: 10.1016/s0092-8674(00)80216-0. [DOI] [PubMed] [Google Scholar]
  148. Zhang Y., LeRoy G., Seelig H. P., Lane W. S., Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell. 1998 Oct 16;95(2):279–289. doi: 10.1016/s0092-8674(00)81758-4. [DOI] [PubMed] [Google Scholar]
  149. Zhang Y., Ng H. H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 1999 Aug 1;13(15):1924–1935. doi: 10.1101/gad.13.15.1924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. van der Vlag J., Otte A. P. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet. 1999 Dec;23(4):474–478. doi: 10.1038/70602. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES